Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain
tumor. Patients with GBM often have poor prognoses, with a median survival of∼ 15 months …

Glioblastoma multiforme (GBM) is a primary malignant brain tumor characterized by a high
grade of malignancy and an extremely unfavorable prognosis. The current efficacy of …

Glioblastoma is a fatal brain tumor, and the standard treatment for this cancer is the surgical
removal of the tumor followed by chemotherapy with temozolomide and radiotherapy …

Seizures are among the most common clinical signs in people with glioblastoma. Advances
over the past 5 years, including new clinical trial data, have increased the understanding of …

The most prevalent and aggressive type of brain cancer, namely, glioblastoma (GBM), is
characterized by intra-and inter-tumor heterogeneity and strong spreading capacity, which …

Glioblastoma multiforme (GBM) has been identified as a frequently occurring adult primary
brain cancer that is highly aggressive. Currently, the prognostic outcome for GBM patients is …

Abstract Background Glioblastomas (GBs) are characterised as one of the most aggressive
primary central nervous system tumours (CNSTs). Single-cell sequencing analysis identified …

Background Animal models representing different molecular subtypes of glioblastoma
multiforme (GBM) is desired for developing new therapies. SVV-001 is an oncolytic virus …

Glioblastoma is an aggressive malignant tumor of the brain and spinal cord. Due to the
blood–brain barrier, the accessibility of its treatments still remains significantly challenging …

Background: Glioma is the most fatal neoplasm among the primary intracranial cancers.
Necroptosis, a form of programmed cell death, is correlated with tumor progression and …